International Dateline

International Dateline

Colorectal Cancer Screening in the Non-Syndromic Familial Risk Population: Is It Time to Revise the Clinical Guidelines?

  • The American Journal of Gastroenterology volume 112, pages 17741776 (2017)
  • doi:10.1038/ajg.2017.403
  • Download Citation
  • Subscribe to The American Journal of Gastroenterology for full access:



Additional access options:

Already a subscriber?  Log in  now or  Register  for online access.


  1. 1.

    , , et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359–86.

  2. 2.

    , , et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 2010;59:666–89.

  3. 3.

    , , . Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer 2006;42:216–27.

  4. 4.

    , , et al. ASGE guideline: colorectal cancer screening and surveillance. Gastrointest Endosc 2006;63:546–57.

  5. 5.

    , , et al. [Clinical practice guideline. Prevention of colorectal cancer. 2009 update. Asociacion Espanola de Gastroenterologia]. Gastroenterol Hepatol 2009;32:717 e1–58.

  6. 6.

    , , et al. Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study. BMJ 2005;331:1047.

  7. 7.

    , , et al. Randomized comparison of surveillance intervals in familial colorectal cancer. J Clin Oncol 2015;33:4188–93.

  8. 8.

    , , et al. Low adherence to colonoscopy in the screening of first-degree relatives of patients with colorectal cancer. Gut 2007;56:1714–8.

  9. 9.

    , , et al. Effectiveness of a colonoscopic screening programme in first-degree relatives of patients with colorectal cancer. Colorectal Dis 2011;13:e145–53.

  10. 10.

    , , et al. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening. Eur J Cancer 2011;47:1571–7.

  11. 11.

    , , et al. Fecal immunochemical test accuracy in familial risk colorectal cancer screening. Int J Cancer 2014;134:367–75.

  12. 12.

    , , et al. Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study. Eur J Gastroenterol Hepatol 2009;21:2–1067.

  13. 13.

    , , et al. Chemical and immunological testing for faecal occult blood in screening subjects at risk of familial colorectal cancer. Gut 1997;40:110–2.

  14. 14.

    , , et al. Serum sCD26 for colorectal cancer screening in family-risk individuals: comparison with faecal immunochemical test. Br J Cancer 2015;112:375–81.

  15. 15.

    , , et al. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening. Gastroenterology 2014;147:1021–30 e1 quiz e16-7.

  16. 16.

    , , et al. Faecal immunochemical test accuracy in patients referred for surveillance colonoscopy: a multi-centre cohort study. BMC Gastroenterol 2012;12:94.

  17. 17.

    , , et al. Risk of advanced neoplasia in first-degree relatives with colorectal cancer: a large multicenter cross-sectional study. PLoS Med 2016;13:e1002008.

  18. 18.

    , , et al. Incidence and mortality of colorectal cancer in individuals with a family history of colorectal cancer. Gastroenterology 2015;149:1438–45 e1.

  19. 19.

    , , et al. Diagnostic accuracy of fecal immunochemical test in patients at increased risk for colorectal cancer: a meta-analysis. JAMA Intern Med 2017;177:1110–8.

  20. 20.

    , , et al. Uptake of colon capsule endoscopy vs colonoscopy for screening relatives of patients with colorectal cancer. Clin Gastroenterol Hepatol 2015;13:2293–301 e1.

Download references

Author information


  1. Servicio de Gastroenterología, Hospital Universitario de Canarias, La Laguna University, La Laguna, Tenerife, Spain

    • Enrique Quintero
    •  & Antonio Z Gimeno-García
  2. Instituto Universitario de Tecnologías Biomédicas (ITB) and Centro de Investigación Biomédica de Canarias (CIBICAN), La Laguna, Tenerife, Spain

    • Enrique Quintero
    •  & Antonio Z Gimeno-García
  3. Departamento de Medicina Interna, La Laguna, Tenerife, Spain

    • Enrique Quintero


  1. Search for Enrique Quintero in:

  2. Search for Antonio Z Gimeno-García in:

Competing interests

Guarantor of article: Enrique Quintero, MD, PhD.

Specific author contributions: Both authors contributed equally to the mansucript.

Financial support: This manuscript was supported by a grants from “Instituto de Salud Carlos III (ISCIII) (PI13/02534 and PI15/01257).

Potential competing interests: None.

Corresponding author

Correspondence to Enrique Quintero.